Refine by
Disease Diagnosis Articles & Analysis: Older
82 news found
Boston: Microneedle technology, driven by high demand in dermatologic procedures and its versatile applications in drug delivery, vaccine administration, and disease diagnostics, faces challenges in its complex manufacturing process. ...
With more than 60 years’ expertise in respiratory diagnostics, Vitalograph is the only company in the world specialized in delivering clinical trial services exclusively for pulmonary function-focused studies. Speaking about the recent additions to their portfolio of services, Richard James, Executive Vice President and Chief Operating Officer of Vitalograph Clinical Trials says: ...
Developed in partnership with Thorasys, the Vitalograph tremoflo® C-100 oscillometer helps to detect the presence of small airway impairment, providing additional information to standard pulmonary function tests. It can aid in the diagnosis of asthma and COPD and can also help identify patients who are at risk of progression to COPD. [1] The tremoflo® C-100 assesses ...
Vitalograph, a global leader in the development and production of respiratory diagnostic solutions and clinical trial services, has launched the Vitalograph tremoflo® C-100 at this year’s ATS International Conference, taking place in Washington. ...
SARS-CoV-2 Detection Raw MaterialsIn response to the demand for accurate and early detection of SARS-CoV-2, which is expected to largely reduce the risk of transmission, a group of detection techniques and methods for improving the efficiency of disease diagnosis have emerged. Nucleic acid detection, antigen detection, and antibody detection are key tools for the ...
Compounding that, nearly a third of patients who are newly diagnosed will have metastatic disease. We are therefore delighted that patients in China will now have a new treatment option for metastatic hormone-sensitive prostate cancer that delays disease progression, extends survival and maintains quality of life”, said Christine Roth, Member of the ...
ByBayer AG
In 2020, an estimated 1.4 million men were diagnosed with prostate cancer, and about 375,000 died from the disease worldwide.3 At the time of diagnosis, most men have localized prostate cancer, meaning their cancer is confined to the prostate gland and can be treated with curative surgery or radiotherapy. Upon relapse, when the disease will ...
ByBayer AG
OCT fundus cameras like the Topcon Maestro2 allow us to see a greater detailed image of the eye to find pathology and manage diseases early.” By cross-cutting the retina in a manner similar to an MRI machine, OCT’s high-resolution imaging creates a 3D map of a patient’s eye, enabling doctors to diagnose eye diseases in a single visit. ...
This recognition continues to validate the extraordinary efforts of those who work tirelessly to help improve patient outcomes, increase access, and reduce cost through point-of-care diagnosis.” Utilizing the CB Insights platform, the research team selected these 150 winners from a pool of over 13,000 private companies, including applicants and nominees. ...
” NanoPin CEO Thomas Tombler, Ph.D., said, "This study demonstrates that advanced new diagnostic approaches can address challenging problems associated with infectious disease that are responsible for significant global mortality. Dr. Hu’s study indicates that such an approach can have a true impact on the global TB epidemic by improving the ...
xCures, Inc. is proud to announce their collaboration with mProbe Inc., a premier CLIA-certified targeted proteomics company. mProbe utilizes a proprietary technology platform integrating artificial intelligence and multi-omic diagnostics to transform the diagnosis, prevention, and treatment of complex diseases such as cancer. ...
ByxCures
A big barrier for virtual health, especially for standalone telehealth companies, is data—the critical health information that allows providers to correctly diagnose certain diseases and conditions and guide patients to better health. A doctor or nurse can’t tell if someone is healthy just by looking at them on a screen. ...
“These results are intriguing and while we cannot make defintive conclusions regarding efficacy, the response does appear quite positive compared to what we know about the disease progression in individuals diagnosed with LADA who display strong signs of autoimmunity”, says PhD Ingrid K Hals, Sponsor’s representative of the trial. ...
Her proven success spans a spectrum of life science companies, including GRAIL and Guardant Health where she developed and executed successful product launch strategies, and at Genentech where she led innovative autoimmune disease treatments through Phase I and II clinical trials with external collaborators. ...
BOSTON – June 22, 2022 – Elucid, a company developing a novel, non-invasive medical software to comprehensively characterize cardiovascular disease, announced the closing of a $27 Million Series B financing round. The round was led by an undisclosed strategic investor, with participation from Biovision Ventures, a new Europe-based fund, and existing investors, including MedTex ...
ByElucid
The Galaxy System is the only fully integrated solution for navigated bronchoscopy, designed to dramatically improve the location accuracy and successful diagnosis of lung nodules using its proprietary TiLT+ Technology™. ...
Altoida, Inc., a precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), today announced the appointment of Dr. Antonella Santuccione Chadha as Chief Medical Officer. In this new role, Dr. Chadha will lead all clinical and medical affairs as the company continues to develop, validate, and commercialize ...
Altoida, Inc., the precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), today announced that it has successfully raised an additional $14 million for its Series A round with new and existing investors. The investment was co-led by M Ventures (the corporate venture capital arm of Merck KGaA, Darmstadt, ...
“With this technology, we can take a step forward in diagnosis and the allocation of different treatments in patients with chronic, severe respiratory failure,” De Backer summarizes. ...
ByFluidda
About Citrine Medicine Citrine Medicine is dedicated to improving the lives of patients with rare and intractable diseases by making diagnosis and essential treatments available and accessible to those who need them in China. Our mission is to build the first rare disease ecosystem in China, and in doing so, enable people with rare ...